基本信息
浏览量:22
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
RESEARCH SUMMARY
My research focuses on developing algorithmic methods for managing, storing, communicating and analyzing high-throughput cancer sequencing data.
Research
A long-time focus of my lab has been discovery and interpretation of large-scale (especially structural) genomic and transcriptomic alterations in tumor samples. Our algorithmic methods for genomic structural variation discovery, including VariationHunter, CommonLAW, DeStruct and NovelSeq, were the first with the ability to handle novel insertions, deletions, inversions and duplications in repetitive regions of the human genome. More recently I have been interested in applying our algorithmic techniques to exact genotyping of highly repetitive, structurally variant genes, e.g., those involved in drug metabolism – for which my group has developed Cypiripi and Aldy methods, and immunoglobulin heavy chain region, for which my group has developed Immunotyper. My group has also contributed to the identification and quantification of transcriptomic aberrations, in particular gene fusions, as well as genic inversions, duplications and deletions in cancer samples. Leading computational methods we have developed include DeFuse, NFuse, Comrad MiStrVar and SVICT (which handles circulating cell-free tumor DNA data). Our most recent focus area is tumor heterogeneity and progression modeling, especially by the use of single-cell sequencing or multi-locus/time series sequencing (for which we have developed CITUP, CTP-Single, Remix-T, BSCITE, PhISCS, CONETT, PhISCS-BnB); my lab has developed the first deep learning method for inferring the progression tree of a tumor. We also work on network-aided, integrative analysis of genomic and transcriptomic sequence data from tumor samples (Hit’nDrive and cdCAP). We have several additional interests within "algorithmic biology" including (i) mapping and variant calling (of/via especially reads from repetitive regions of the genome – or involving reads with high error rates – examples include mrFAST, mrsFAST, drFAST and lordFAST, or reads extracted from cell free tumor DNA - e.g. SINVICT), (ii) genomic data compression (SCALCE, DeeZ and AssemblTrie), (iii) secure/privacy preserving computing (PrivStrat, SkSES and SMac) and (iv) metagenomic binning (CAMMiQ).
My research focuses on developing algorithmic methods for managing, storing, communicating and analyzing high-throughput cancer sequencing data.
Research
A long-time focus of my lab has been discovery and interpretation of large-scale (especially structural) genomic and transcriptomic alterations in tumor samples. Our algorithmic methods for genomic structural variation discovery, including VariationHunter, CommonLAW, DeStruct and NovelSeq, were the first with the ability to handle novel insertions, deletions, inversions and duplications in repetitive regions of the human genome. More recently I have been interested in applying our algorithmic techniques to exact genotyping of highly repetitive, structurally variant genes, e.g., those involved in drug metabolism – for which my group has developed Cypiripi and Aldy methods, and immunoglobulin heavy chain region, for which my group has developed Immunotyper. My group has also contributed to the identification and quantification of transcriptomic aberrations, in particular gene fusions, as well as genic inversions, duplications and deletions in cancer samples. Leading computational methods we have developed include DeFuse, NFuse, Comrad MiStrVar and SVICT (which handles circulating cell-free tumor DNA data). Our most recent focus area is tumor heterogeneity and progression modeling, especially by the use of single-cell sequencing or multi-locus/time series sequencing (for which we have developed CITUP, CTP-Single, Remix-T, BSCITE, PhISCS, CONETT, PhISCS-BnB); my lab has developed the first deep learning method for inferring the progression tree of a tumor. We also work on network-aided, integrative analysis of genomic and transcriptomic sequence data from tumor samples (Hit’nDrive and cdCAP). We have several additional interests within "algorithmic biology" including (i) mapping and variant calling (of/via especially reads from repetitive regions of the genome – or involving reads with high error rates – examples include mrFAST, mrsFAST, drFAST and lordFAST, or reads extracted from cell free tumor DNA - e.g. SINVICT), (ii) genomic data compression (SCALCE, DeeZ and AssemblTrie), (iii) secure/privacy preserving computing (PrivStrat, SkSES and SMac) and (iv) metagenomic binning (CAMMiQ).
研究兴趣
论文共 246 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Welles Robinson, Joshua K. Stone,Fiorella Schischlik, Billel Gasmi, Michael C. Kelly, Charlie Seibert, Kimia Dadkhah,E. Michael Gertz,Joo Sang Lee,Kaiyuan Zhu, Lichun Ma, Xin Wei Wang,
biorxiv(2023)
Frontiers in oncology (2023): 1199741
Charli Gruen,Howard H. Yang, Antonella Sassano,Emily Wu,Vishaka Gopalan,Kerrie L. Marie, Andrea Castro,Farid Rashidi Mehrabadi,Chih Hao Wu, Isabella Church,Gabriel A. Needle,Cari Smith,
crossref(2023)
Yuelin Liu,Xuan Cindy Li,Farid Rashidi Mehrabadi, Alejandro A. Schäffer, Drew Pratt, David R. Crawford,Salem Malikić, Erin K. Molloy, Vishaka Gopalan,Stephen M. Mount,Eytan Ruppin,Kenneth Aldape,
biorxiv(2023)
Natureno. 7948 (2023): E42-E42
Genome Researchno. 1 (2023): 61-70
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn